Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The history table now includes additional versions with updated study status and related changes. The new screenshot shows more recent submission dates added to the record history.
    Difference
    0.1%
    Check dated 2025-11-03T13:11:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    10%
    Check dated 2025-10-05T17:39:51.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-28T11:10:46.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock, or time-related information.
    Difference
    0.6%
    Check dated 2025-09-14T00:42:13.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.6%
    Check dated 2025-09-06T21:32:36.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has added significant details regarding a facility and its location, including the name AbbVie and various study statuses with specific dates, while removing references to certain locations and a previous sponsor, TeneoOne Inc.
    Difference
    47%
    Check dated 2025-08-30T16:05:57.000Z thumbnail image

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.